Thiamin diphosphate‐dependent enzymes: from enzymology to metabolic regulation, drug design and disease models

Bringing a knowledge of enzymology into research in vivo and in situ is of great importance in understanding systems biology and metabolic regulation. The central metabolic significance of thiamin (vitamin B 1 ) and its diphosphorylated derivative (thiamin diphosphate; Th DP ), and the fundamental differences in the Th DP ‐dependent enzymes of metabolic networks in mammals versus plants, fungi and bacteria, or in health versus disease, suggest that these enzymes are promising targets for biotechnological and medical applications. Here, the in vivo action of known regulators of Th DP ‐dependent enzymes, such as synthetic structural analogs of the enzyme substrates and thiamin, is analyzed in light of the enzymological data accumulated during half a century of research. Mimicking the enzyme‐specific catalytic intermediates, the phosphonate analogs of 2‐oxo acids selectively inhibit particular Th DP ‐dependent enzymes. Because of their selectivity, use of these compounds in cellular and animal models of Th DP ‐dependent enzyme malfunctions improves the validity of the model and its predictive power when compared with the nonselective and enzymatically less characterized oxythiamin and pyrithiamin. In vitro studies of the interaction of thiamin analogs and their biological derivatives with potential in vivo targets are necessary to identify and attenuate the analog selectivity. For both the substrate and thiamin synthetic analogs, in vitro reactivities with potential targets are highly relevant in vivo . However, effective concentrations in vivo are often higher than in vitro studies would suggest. The significance of specific inihibition of the Th DP ‐dependent enzymes for the development of herbicides, antibiotics, anticancer and neuroprotective strategies is discussed.